April 29, 2011 Robert Connolly Managing Director and General Counsel BlackRock Advisors, LLC c/o BlackRock Inc. New York, NY 10022 Dear Mr. Connolly:
(d)(3)(ii)
April 29, 2011
Xxxxxx Xxxxxxxx
Managing Director and General Counsel
BlackRock Advisors, LLC
c/o BlackRock Inc.
00 Xxxx 00xx Xxxxxx
New York, NY 10022
Dear Xx. Xxxxxxxx:
Pursuant to Section 1 of the Sub-Advisory Agreement dated February 2, 2007, as amended, between ING Investments, LLC and BlackRock Advisors, LLC, (the “Agreement”), we hereby notify you of our intention to modify the annual sub-adviser fee for ING BlackRock Science and Technology Opportunities Portfolio (the “Portfolio”) by aggregating the assets of the Portfolio with the assets of ING BlackRock Health Sciences Opportunities Portfolio, formerly, ING Xxxxx Fargo Health Care Portfolio, a series of ING Investors Trust, effective April 29, 2011. Upon your acceptance, the Agreement will be modified to give effect to the foregoing by amending the Amended Schedule A of the Agreement. The Amended Schedule A, with the annual sub-advisory fees indicated for the Portfolio, is attached hereto.
Please signify your acceptance to the modification of the sub-adviser fee for the Portfolio by signing below where indicated.
Very sincerely, |
/s/ Xxxx Xxxxx |
Xxxx Xxxxx |
Senior Vice President |
ING Investments, LLC |
ACCEPTED AND AGREED TO: | ||
BlackRock Advisors, LLC | ||
By: | /s/ Xxxxx Xxxxxxxx | |
Name: | Xxxxx Xxxxxxxx | |
Title: | Managing Director, Duly Authorized |
0000 X. Xxxxxxxxxx Xxxxx Xx. Suite 100 Scottsdale, AZ 00000-0000 |
Tel: 000-000-0000 Fax: 000-000-0000 xxx.xxxxxxxx.xxx |
ING Investments, LLC |
AMENDED SCHEDULE A
with respect to the
between
ING INVESTMENTS, LLC
and
BLACKROCK ADVISORS, LLC
Series |
Annual Sub-Adviser Fee (as a percentage of average daily net assets) | |
ING BlackRock Science and Technology Opportunities Portfolio1 | 0.50% on first $200 million of assets 0.425% on next $300 million of assets 0.40% on assets thereafter |
1 | For purposes of calculating fees under this Agreement, the assets of the Series shall be aggregated with the assets of ING BlackRock Health Sciences Opportunities Portfolio, formerly, ING Xxxxx Fargo Health Care Portfolio, a series of ING Investors Trust, a registered investment company that is not a party to this Agreement. The aggregated assets will be applied to the above schedule and the resulting fee shall be prorated back to these two series and their respective Sub-Adviser based on relative net assets. |
2